A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.
- Authors
- Leniger, Tobias; Kananura, Colette; Hufnagel, Andreas; Bertrand, Sonia; Bertrand, Daniel; Steinlein, Ortrud K
- Year
- 2003
- Journal
- Epilepsia
- PMID
- 12823585
- DOI
- 10.1046/j.1528-1157.2003.61102.x
PURPOSE: To identify and characterize the mutation(s) causing nocturnal frontal lobe epilepsy in a German extended family. METHODS: Neuronal nicotinic acetylcholine receptor (nAChR) subunit genes were screened by direct sequencing. Once a CHRNA4 mutation was identified, its biophysical and pharmacologic properties were characterized by expression experiments in Xenopus oocytes. RESULTS: We report a new CHRNA4 mutation, causing a alpha4-T265I amino acid exchange at the extracellular end of the second transmembrane domain (TM). Functional studies of alpha4-T265I revealed an increased ACh sensitivity of the mutated receptors. alpha4-T265I is associated with an unusual low penetrance of the epilepsy phenotype. Sequencing of the TM1-TM3 parts of the 1 known nAChR subunits did not support a two-locus model involving a second nAChR sequence variation. CONCLUSIONS: nAChR mutations found in familial epilepsy are not always associated with an autosomal dominant mode of inheritance. alpha4-T265I is the first nAChR allele showing a markedly reduced penetrance consistent with a major gene effect. The low penetrance of the mutation is probably caused by unknown genetic or environmental factors or both.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans. | 2019 | 31740666 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Clinical, molecular, physiologic, and therapeutic feature of patients with CHRNA4 and CHRNB2 deficiency: A systematic review. | Jalaiei A et al. | β | 2025 | β |
| Emerging Role of Tripartite Synaptic Transmission in the Pathomechanism of Autosomal-Dominant Sleep-Related Hypermotor Epilepsy. | Oka T et al. | β | 2025 | β |
| Two Novel Variants in the <i>CHRNA2</i> and <i>SCN2A</i> Genes in Italian Patients with Febrile Seizures. | Procopio R et al. | β | 2024 | β |
| Nicotinic acetylcholine receptors in neurological and psychiatric diseases. | Terry AV et al. | β | 2023 | β |
| Two novel variants of the STXBP1 and CHRNB2 genes identified in a Chinese boy with refractory seizures and developmental delay. | Wang S et al. | β | 2023 | β |
| Can rodent models elucidate the pathomechanisms of genetic epilepsy? | Okada M | β | 2022 | β |
| Genetic Variant in Nicotinic Receptor Ξ±4-Subunit Causes Sleep-Related Hyperkinetic Epilepsy via Increased Channel Opening. | Mazzaferro S et al. | β | 2022 | β |
| A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans. | Cheng Z et al. | β | 2019 | β |
| Paroxysmal Movement Disorders: Recent Advances. | Xu Z et al. | β | 2019 | β |
| Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry. | Indurthi DC et al. | β | 2019 | β |
| A Caenorhabditis elegans assay of seizure-like activity optimised for identifying antiepileptic drugs and their mechanisms of action. | Wong SQ et al. | β | 2018 | β |
| Transcriptome of the Wistar audiogenic rat (WAR) strain following audiogenic seizures. | Damasceno S et al. | β | 2018 | β |
| Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy. | Wei F et al. | β | 2017 | β |
| Novel Mutations in Synaptic Transmission Genes Suppress Neuronal Hyperexcitation in <i>Caenorhabditis elegans</i>. | McCulloch KA et al. | β | 2017 | β |
| Genetic models of focal epilepsies. | Boillot M et al. | β | 2016 | β |
| Genetic neurological channelopathies: molecular genetics and clinical phenotypes. | Spillane J et al. | β | 2016 | β |
| Nocturnal frontal lobe epilepsy caused by a mutation in the GATOR1 complex gene NPRL3. | Korenke GC et al. | β | 2016 | β |
| Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy. | Chen Z et al. | β | 2015 | β |
| Pathologic role of neuronal nicotinic acetylcholine receptors in epileptic disorders: implication for pharmacological interventions. | Ghasemi M et al. | β | 2015 | β |
| The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy. | Becchetti A et al. | β | 2015 | β |
| A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in a Chinese patient with non-familial nocturnal frontal lobe epilepsy. | Wang MY et al. | β | 2014 | β |
| Genetic background of febrile seizures. | Saghazadeh A et al. | β | 2014 | β |
| Nocturnal frontal lobe epilepsy. | Nobili L et al. | β | 2014 | β |
| Nonlesional focal epilepsy: a challenge from genes to surgery. | Andrade DM | β | 2013 | β |
| Ligand-gated ion channels: new insights into neurological disorders and ligand recognition. | Lemoine D et al. | β | 2012 | β |
| Mutations in familial nocturnal frontal lobe epilepsy might be associated with distinct neurological phenotypes. | Steinlein OK et al. | β | 2012 | β |
| Neuronal nicotinic receptors in sleep-related epilepsy: studies in integrative biology. | Becchetti A | β | 2012 | β |
| Nocturnal frontal lobe epilepsy and the acetylcholine receptor. | Ferini-Strambi L et al. | β | 2012 | β |
| Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the Ξ²2 nicotinic receptor. | Xu J et al. | β | 2011 | β |
| The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: Its possible implication in non-familial nocturnal frontal lobe epilepsy. | Liu H et al. | β | 2011 | β |
| The sleep manifestations of frontal lobe epilepsy. | Derry CP | β | 2011 | β |
| Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures. | Steinlein OK | β | 2010 | β |
| Nicotinic receptor channelopathies and epilepsy. | Steinlein OK et al. | β | 2010 | β |
| A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. | Chen Y et al. | β | 2009 | β |
| CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients. | Combi R et al. | β | 2009 | β |
| Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy - part 1. | Badawy RA et al. | β | 2009 | β |
| Genes associated with idiopathic epilepsies: a current overview. | Lu Y et al. | β | 2009 | β |
| Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors. | Picard F et al. | β | 2009 | β |
| Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene. | Hoda JC et al. | β | 2009 | β |
| Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore. | Hoda JC et al. | β | 2008 | β |
| Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases. | Steinlein OK et al. | β | 2008 | β |
| Properties of mutated murine alpha4beta2 nicotinic receptors linked to partial epilepsy. | Lipovsek M et al. | β | 2008 | β |
| Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype. | Zhu G et al. | β | 2008 | β |
| Genetic disorders caused by mutated acetylcholine receptors. | Steinlein OK | β | 2007 | β |
| The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. | Marini C et al. | β | 2007 | β |
| Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. | Picard F et al. | β | 2006 | β |
| Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. | Klaassen A et al. | β | 2006 | β |
| Clinical and genetic aspects of idiopathic epilepsies in childhood. | Callenbach PM et al. | β | 2005 | β |
| Genetic focal epilepsies: state of the art and paths to the future. | Andermann F et al. | β | 2005 | β |
| Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the alpha 4 beta 2 nicotinic acetylcholine receptor. | Rodrigues-Pinguet NO et al. | β | 2005 | β |
| Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors. | Fonck C et al. | β | 2005 | β |
| Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)". | di Corcia G et al. | β | 2005 | β |
| The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. | Bertrand D et al. | β | 2005 | β |
| The possible contribution of neuronal nicotinic acetylcholine receptors in depression. | Bertrand D | β | 2005 | β |
| Two new putative susceptibility loci for ADNFLE. | Combi R et al. | β | 2005 | β |
| Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview. | Combi R et al. | β | 2004 | β |
| Evidence for a fourth locus for autosomal dominant nocturnal frontal lobe epilepsy. | Combi R et al. | β | 2004 | β |
| Genes and mutations in human idiopathic epilepsy. | Steinlein OK | β | 2004 | β |
| Genetics of the epilepsies. | Gutierrez-Delicado E et al. | β | 2004 | β |
| Infantile convulsions and paroxysmal choreoathetosis in a consanguineous family. | Demir E et al. | β | 2004 | β |
| Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel. | Otto JF et al. | β | 2004 | β |
| Monogenic idiopathic epilepsies. | Gourfinkel-An I et al. | β | 2004 | β |
| Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds. | Hogg RC et al. | β | 2004 | β |